varieti
n
substitut
imino
methyl
benzyliden
substitut
benzohydrazid
synthes
evalu
antimicrobi
anticanc
potenti
result
test
antimicrobi
activ
indic
potent
antimicrobi
agent
pmic
synthes
compound
bacteriostat
fungistat
action
result
evalu
antivir
activ
indic
none
synthes
hydrazid
deriv
inhibit
viral
replic
subtox
concentr
result
antihiv
screen
strain
rod
indic
one
compound
potent
ic
c
lgcm
standard
drug
nevirapin
ic
c
lgcm
anoth
equipot
ic
c
lgcm
effect
anticanc
agent
cancer
cell
line
ic
lgcm
respect
qsar
analysi
indic
import
wiener
index
w
energi
lowest
unoccupi
molecular
orbit
lumo
describ
antimicrobi
activ
synthes
compound
dramat
rise
preval
multidrugresist
microbi
infect
past
decad
becom
seriou
health
care
problem
particular
emerg
multidrug
resist
strain
gramposit
bacteri
pathogen
exampl
methicillinresist
staphylococcu
aureu
staphylococcu
epidermi
vancomycinresist
enterococcu
problem
everincreas
signific
one
way
overcom
challeng
control
use
current
market
antibiot
anoth
develop
novel
antimicrobi
agent
consequ
search
new
antimicrobi
agent
remain
import
challeng
task
medicin
chemist
acquir
immun
defici
syndrom
aid
becom
global
pandem
claim
live
diseas
accord
unaid
report
releas
million
peopl
diagnos
human
immunodefici
viru
hiv
posit
human
lymphocyt
target
cell
hiv
replic
cell
line
use
screen
antihiv
agent
recent
year
much
attent
devot
search
effect
chemotherapeut
agent
inhibit
hiv
minimum
side
effect
cancer
diseas
worldwid
import
incid
develop
countri
increas
mortal
rank
second
order
caus
death
similar
tendenc
observ
develop
world
gradual
improv
life
expect
associ
elev
cancer
incid
mortal
malign
consecut
burden
therefor
global
problem
result
widespread
interest
cancer
therapi
synthesi
novel
pharmacolog
activ
molecul
reduc
toxic
prime
interest
recent
quantit
structureact
relationship
qsar
gain
import
medicin
chemistri
qsar
predict
tool
use
preliminari
evalu
activ
chemic
compound
use
computeraid
model
use
qsar
increas
probabl
success
drugdiscoveri
process
reduc
time
cost
involv
hydrazon
attract
attent
mani
chemist
owe
wide
rang
biolog
activ
literatur
report
reveal
chemistri
biolog
hydrazon
intens
investig
past
decad
hydrazon
deriv
found
antimicrobi
anticanc
antimycobacteri
antimalari
antioxid
anticonvuls
analges
antiinflammatori
antidiabet
activ
motiv
fact
continu
research
effort
synthesi
evalu
antimicrobi
activ
qsar
studi
report
herein
synthesi
antimicrobi
antivir
anticanc
evalu
qsar
studi
n
substitut
imino
methyl
benzyliden
substitut
benzohydrazid
chemistri
synthesi
target
compound
perform
outlin
scheme
compound
highmeltingpoint
solid
mp
structur
compound
ascertain
basi
consist
ir
nmr
mass
spectral
characterist
result
element
c
h
n
analysi
full
agreement
assign
molecular
structur
synthes
compound
screen
invitro
antibacteri
activ
aureu
bacillu
subtili
escherichia
coli
antifung
activ
candida
albican
aspergillu
niger
tube
dilut
method
use
norfloxacin
fluconazol
refer
standard
antibacteri
antifung
activ
respect
result
present
tabl
among
synthes
compound
n
methyl
benzyliden
n
methyl
benzyliden
n
methyl
benzyliden
found
effect
aureu
pmic
sa
valu
respect
b
subtili
e
coli
c
albican
compound
emerg
effect
antimicrobi
agent
pmic
valu
antivir
assay
base
inhibit
virusinduc
cytopath
crfk
hel
vero
hela
cell
cultur
result
antivir
evalu
given
tabl
none
synthes
hydrazid
deriv
inhibit
viral
replic
subtox
concentr
antihiv
activ
cytotox
evalu
strain
iiib
strain
rod
cell
cultur
use
bromid
mtt
method
tabl
result
indic
compound
ic
c
lgcm
potent
standard
drug
nevirapin
ic
c
lgcm
strain
rod
compound
ic
c
lgcm
found
equipot
anticanc
activ
synthes
hydrazid
deriv
human
colon
cancer
breast
cancer
cell
line
determin
use
tetrazolium
bromid
mtt
assay
result
present
tabl
gener
synthes
compound
poor
anticanc
potenti
compound
effect
cancer
cell
line
ic
valu
lgcm
respect
compound
effect
cancer
cell
line
ic
valu
lgcm
respect
result
antimicrobi
antivir
anticanc
evalu
reveal
natur
substitu
substanti
effect
biolog
activ
target
hydrazon
structureact
relationship
sar
discuss
deduc
result
antimicrobi
screen
indic
presenc
electronwithdraw
substitu
phenylimino
structur
compound
increas
antimicrobi
activ
aureu
b
subtili
e
coli
c
albican
wherea
presenc
electronwithdraw
nitro
group
benzoic
acid
structur
chloro
group
phenylimino
structur
increas
antifung
activ
niger
import
note
incub
temperatur
three
bacteri
speci
c
albican
fungu
similar
incub
condit
may
reason
higher
activ
compound
c
albican
bacteri
speci
effect
electronwithdraw
group
improv
antimicrobi
activ
support
studi
sharma
et
al
presenc
electronreleas
group
benzoic
acid
structur
increas
antihiv
activ
synthes
compound
presenc
electronreleas
group
benzoic
acid
structur
increas
anticanc
potenti
synthes
compound
effect
electronreleas
group
improv
anticanc
potenti
benzodiazepin
deriv
similar
observ
kamal
et
al
presenc
imino
moieti
improv
antimicrobi
anticanc
potenti
synthes
compound
except
propylimino
moieti
improv
anticanc
activ
human
colon
cancer
cell
line
hct
presenc
moieti
synthes
compound
improv
antimicrobi
anticanc
potenti
aforement
result
indic
differ
structur
requir
essenti
compound
select
antibacteri
antifung
agent
similar
result
obtain
sortino
et
al
identifi
effect
substitu
antimicrobi
activ
quantit
structureact
relationship
qsar
tabl
use
depend
variabl
qsar
studi
differ
molecular
descriptor
independ
variabl
exampl
logarithm
octanolwat
partit
coeffici
log
p
molar
refract
mr
kier
molecular
connect
v
v
v
shape
j
ja
ja
ja
topolog
indic
randic
topolog
index
r
balaban
topolog
index
j
wiener
topolog
index
w
total
energi
te
energi
highest
occupi
molecular
orbit
homo
lowest
unoccupi
molecular
orbit
lumo
dipol
moment
l
electron
energi
ele
e
calcul
hydrazid
deriv
valu
obtain
present
tabl
earlier
studi
indic
multitarget
qsar
mtqsar
model
suitabl
onetarget
qsar
otqsar
model
describ
antimicrobi
activ
studi
therefor
develop
multitarget
qsar
model
describ
antimicrobi
activ
compound
otqsar
model
one
use
five
differ
equat
differ
error
predict
activ
new
compound
five
microbi
speci
use
otqsar
model
use
almost
throughout
literatur
practic
howev
predict
compound
action
one
target
case
develop
one
otqsar
model
target
howev
recent
interest
increas
develop
multitarget
qsar
mtqsar
model
oppos
otqsar
mtqsar
model
singl
equat
consid
natur
molecular
descriptor
common
essenti
describ
antibacteri
antifung
activ
studi
attempt
develop
three
differ
type
mtqsar
model
viz
mtqsar
model
describ
antibacteri
activ
synthes
compound
aureu
b
subtili
e
coli
mtqsar
model
describ
antifung
activ
synthes
compound
c
albican
niger
common
mtqsar
model
describ
antimicrobi
overal
antibacteri
antifung
activ
synthes
hydrazid
deriv
mention
microorgan
develop
mtqsar
model
initi
calcul
averag
antibacteri
antifung
antimicrobi
activ
hydrazid
deriv
tabl
averag
antibacteri
activ
valu
correl
molecular
descriptor
synthes
compound
tabl
high
interrelationship
observ
among
topolog
indic
wiener
index
w
randic
index
r
r
low
interrelationship
observ
lipophil
paramet
log
p
electron
properti
energi
highest
occupi
molecular
orbit
homo
r
correl
averag
antibacteri
antifung
antimicrobi
activ
valu
differ
molecular
descriptor
shown
tabl
correl
matrix
tabl
observ
electron
properti
total
energi
te
domin
descript
antibacteri
activ
synthes
compound
eq
lrmtqsar
model
antibacteri
activ
pmic
ab
n
number
data
point
r
correl
coeffici
q
cross
valid
r
obtain
leaveoneout
loo
method
standard
error
estim
f
fischer
statist
coeffici
te
eq
neg
antibacteri
activ
synthes
compound
decreas
increas
te
valu
evidenc
high
antibacteri
activ
compound
pmic
ab
lmcm
low
te
valu
te
improv
valu
correl
coeffici
r
electron
properti
total
energi
te
coupl
lipophil
log
p
result
r
valu
increas
eq
mlrmtqsar
model
antibacteri
activ
pmic
ab
log
p
develop
model
cross
valid
loo
method
q
valu
eq
show
develop
model
invalid
accord
recommend
kim
et
al
howev
regress
model
accept
valu
standard
deviat
sd
tabl
valu
standard
deviat
develop
model
eq
valid
one
furthermor
observ
predict
antibacteri
activ
valu
close
tabl
mtqsar
model
antibacteri
activ
eq
valid
one
plot
predict
pmic
ab
observ
pmic
ab
fig
also
favour
develop
model
express
eq
plot
observ
pmic
ab
versu
residu
pmic
ab
fig
indic
system
error
model
develop
propag
error
observ
side
zero
kier
secondord
shape
index
j
found
domin
descriptor
explain
antifung
activ
synthes
substitut
hydrazid
deriv
tabl
lrmtqsar
model
antifung
activ
clearli
evid
eq
antifung
activ
synthes
compound
posit
correl
kier
secondord
shape
index
j
ie
antifung
activ
compound
increas
increas
j
valu
high
antifung
activ
compound
pmic
af
high
j
valu
j
illustr
posit
correl
use
topolog
indic
second
gener
j
indic
molecular
shape
flexibl
accord
kier
shape
molecul
may
partit
attribut
describ
count
bond
variou
path
length
basi
devis
rel
index
shape
given
relationship
number
path
length
l
molecul
l
p
refer
valu
base
molecul
given
number
atom
n
valu
l
p
maximum
minimum
l
p
max
l
p
min
firstord
shape
attribut
j
given
express
second
thirdord
kappa
indic
defin
follow
coupl
topolog
index
kier
second
order
shape
index
j
electron
properti
energi
lowest
unoccupi
molecular
orbit
lumo
result
increas
r
valu
eq
mlrmtqsar
model
antifung
activ
pmic
af
lumo
although
q
valu
deriv
eq
loo
method
made
model
invalid
low
residu
valu
observ
antifung
activ
predict
use
eq
tabl
low
standard
deviat
tabl
result
qsar
model
antifung
activ
valid
one
antimicrobi
activ
synthes
hydrazid
deriv
best
explain
topolog
index
wiener
index
w
tabl
lrmtqsar
model
antimicrobi
activ
wiener
index
w
w
g
g
defin
half
sum
element
distanc
matrix
ij
ijth
element
distanc
matrix
denot
shortest
graphtheoret
distanc
site
j
g
similar
antifung
activ
antimicrobi
activ
synthes
compound
also
posit
correl
wiener
index
w
tabl
addit
electron
properti
energi
lowest
unoccupi
molecular
orbit
lumo
topolog
index
w
result
best
model
describ
antimicrobi
activ
synthes
compound
eq
mlrmtqsar
model
antimicrobi
activ
electron
properti
lumo
denot
energi
lowest
unoccupi
molecular
orbit
directli
relat
electron
affin
character
sensit
molecul
attack
nucleophil
contribut
lumo
describ
antimicrobi
activ
may
attribut
interact
hydrazid
deriv
nucleophil
amino
acid
residu
exampl
cystein
microorgan
valid
predict
qsar
model
antimicrobi
activ
ie
eq
evidenc
high
q
valu
q
obtain
loo
method
low
residu
activ
valu
tabl
summari
qsar
analysi
indic
import
topolog
index
wiener
index
w
electron
properti
energi
lowest
unoccupi
molecular
orbit
lumo
describ
antimicrobi
activ
n
substitut
imino
methyl
benzyliden
substitut
benzohydrazid
gener
qsar
studi
biolog
activ
compound
span
two
three
order
magnitud
studi
rang
antimicrobi
activ
synthes
compound
within
one
order
magnitud
similar
result
obtain
bajaj
et
al
state
reliabl
qsar
model
lie
predict
abil
even
though
activ
data
narrow
rang
biolog
activ
data
narrow
rang
low
standard
deviat
biolog
activ
justifi
use
qsar
studi
low
standard
deviat
observ
antimicrobi
activ
data
tabl
justifi
use
qsar
studi
mixtur
mmol
substitut
benzoic
acid
g
cm
mol
ethanol
heat
reflux
presenc
sulfur
acid
complet
reaction
reaction
complet
reaction
mixtur
ad
cm
icecold
water
ester
form
extract
cm
ether
ether
layer
separ
evapor
yield
crude
ester
recrystal
alcohol
hydrazin
hydrat
mol
ad
ethanol
solut
ester
mol
mixtur
heat
reflux
h
reaction
mixtur
cool
precipit
isol
filtrat
wash
water
dri
recrystal
ethanol
solut
g
terephthaldehyd
mmol
cm
ethanol
ad
solut
substitut
benzoic
acid
hydrazid
synthes
mol
cm
ethanol
mixtur
heat
reflux
h
reaction
mixtur
left
cool
room
temperatur
precipit
hydrazon
isol
filtrat
dri
recrystal
ethanol
solut
mmol
synthes
hydrazon
cm
dmf
ad
solut
mmol
substitut
cm
dmf
mixtur
heat
reflux
h
follow
cool
ice
bath
result
product
isol
filtrat
purifi
antihiv
activ
cytotox
evalu
strain
iiib
strain
rod
cell
cultur
use
bromid
mtt
method
briefli
viru
stock
titrat
cell
express
cell
cultur
infect
dose
ccid
cell
suspend
cultur
medium
cellscm
infect
hiv
multipl
infect
immedi
viral
infect
mm
cell
suspens
place
well
flatbottom
microtit
tray
contain
differ
concentr
test
compound
incub
four
day
number
viabl
cell
determin
use
mtt
method
compound
test
parallel
cytotox
effect
uninfect
cell
anticanc
activ
compound
determin
human
colon
breast
cancer
cell
line
cell
line
cultur
rpmi
sigma
supplement
heatinactiv
fetal
bovin
serum
fb
paa
laboratori
penicillinstreptomycin
paa
laboratori
cultur
maintain
humidifi
incub
atmospher
co
anticanc
activ
synthes
compound
differ
concentr
assess
use
tetrazolium
bromid
mtt
sigma
assay
describ
mosmann
minor
modif
incub
h
assay
plate
read
use
spectrophotomet
nm
data
gener
use
plot
doserespons
curv
concentr
test
compound
requir
kill
cell
popul
ic
determin
anticanc
activ
express
mean
ic
three
independ
experi
structur
first
preoptim
use
mm
procedur
includ
hyperchem
result
geometri
refin
mean
semiempir
method
parametr
chose
gradient
norm
limit
geometri
optim
lowest
energi
structur
use
molecul
calcul
physicochem
properti
use
tsar
softwar
window
regress
analysi
perform
use
spss
softwar
packag
